121 related articles for article (PubMed ID: 4019272)
1. Combination of 60Co gamma-radiation, misonidazole, and maltose tetrapalmitate in the treatment of Dunning prostatic tumor in the rat.
Pageau R; Nigam VN; Fisher GJ; Brailovsky CA; Fathi MA; Corcos J; Tahan TW; Elhilali MM
Int J Radiat Oncol Biol Phys; 1985 Aug; 11(8):1483-7. PubMed ID: 4019272
[TBL] [Abstract][Full Text] [Related]
2. The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
El Kappany H; Chopra C; Nigam VN; Brailovsky CA; Elhilali M
Br J Cancer; 1980 Nov; 42(5):703-11. PubMed ID: 7459208
[TBL] [Abstract][Full Text] [Related]
3. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM
Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897
[TBL] [Abstract][Full Text] [Related]
4. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
Siemann DW; Hill SA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Dunning R3327-AT rat prostate tumors with photodynamic therapy in combination with misonidazole.
Gonzalez S; Arnfield MR; Meeker BE; Tulip J; Lakey WH; Chapman JD; McPhee MS
Cancer Res; 1986 Jun; 46(6):2858-62. PubMed ID: 3698010
[TBL] [Abstract][Full Text] [Related]
7. The effect of maltose tetrapalmitate (MTP) on prostate cancer growth in vivo and in vitro.
Nguyen NM; Lehr JE; Shelley CI; Andersen JC; Pienta KJ
Anticancer Res; 1993; 13(6A):2053-8. PubMed ID: 7507653
[TBL] [Abstract][Full Text] [Related]
8. Treatment of bladder carcinoma with irradiation combined with misonidazole.
Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
[TBL] [Abstract][Full Text] [Related]
9. Combined radiotherapy, chemotherapy, and maltose tetrapalmitate immunotherapy in the treatment of 4'dimethylaminoazobenzene-induced liver cancer.
Nigam VN; Brière N; Bonaventure J; Pageau R; Bissonnette E; Brailovsky C; Madarnas P
Anticancer Res; 1986; 6(2):245-50. PubMed ID: 3085575
[TBL] [Abstract][Full Text] [Related]
10. The effect of prolonged high dose misonidazole on tumor response to radiation.
McNally NJ; de Ronde J; Hinchliffe M
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
Ibraheim EH; El Kappany H; Nigam VN; Brailovsky CA; Madarnas P; Elhilali MM
Anticancer Res; 1984; 4(3):209-13. PubMed ID: 6465859
[TBL] [Abstract][Full Text] [Related]
12. Response of an experimental mammary carcinoma to fractionated X-irradiation with misonidazole and microwave hyperthermia.
Goldfeder A; Brown DM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1287-91. PubMed ID: 6469752
[TBL] [Abstract][Full Text] [Related]
13. Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal cancers in CDI mice.
Benrezzak O; Madarnas P; Pageau R; Nigam VN
Anticancer Res; 1988; 8(3):499-506. PubMed ID: 3389753
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer.
Tamura M; Inoue H; Murata M; Koizumi H; Nakamura M; Yonome I; Niibe H
J Cancer Res Clin Oncol; 1985; 109(3):188-92. PubMed ID: 4008513
[TBL] [Abstract][Full Text] [Related]
15. Misonidazole combined with hyperfractionation in the management of malignant glioma.
Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. I. Biological studies.
Benrezzak O; Madarnas P; Pageau R; Nigam VN; Elhilali MM
Anticancer Res; 1989; 9(6):1883-7. PubMed ID: 2627134
[TBL] [Abstract][Full Text] [Related]
17. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
Yu NY; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
[TBL] [Abstract][Full Text] [Related]
18. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
Overgaard J
Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
[TBL] [Abstract][Full Text] [Related]
19. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
20. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
Siemann DW; Morrissey S; Wolf K
Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
